Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
34.00
-0.27 (-0.79%)
At close: Sep 18, 2026, 4:00 PM EDT
34.25
+0.25 (0.74%)
After-hours: Sep 18, 2026, 7:48 PM EDT
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $2.45 billion as of September 18, 2026. Its market cap has increased by 56.44% in one year.
Market Cap
2.45B
Enterprise Value
2.03B
1-Year Change
56.44%
Ranking
Category
Stock Price
$34.00
ChartMarket Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $2.45B, an increase of 987.64%. That is a compound annual growth rate of 56.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.45B | -31.84% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 2.46B |
| Mineralys Therapeutics | 2.43B |
| SELLAS Life Sciences Group | 2.35B |
| Beam Therapeutics | 2.31B |
| Nektar Therapeutics | 2.30B |
| Aurinia Pharmaceuticals | 2.26B |
| Palvella Therapeutics | 2.18B |
| Ocular Therapeutix | 2.17B |